Related Experiment Video
Updated: Jul 8, 2026
Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in Germany
Johanna Ernst1, Katharina Alfter1, Alexander Mustea2
1Department of Integrated Oncology - CIO Bonn, University Hospital Bonn, Bonn, Germany.
Background/Aim:
Tumor boards (TUBs) are interdisciplinary meetings designed to determine the most effective cancer therapies and improve patient outcomes. This study aimed to assess which TUB therapy recommendations were easily implemented and to identify factors that hindered their implementation in clinical practice.
Patients And Methods:
In this retrospective study, data from ten TUBs held at the University Hospital Bonn between 2014 and 2016 were analyzed. The dataset included 7,152 patients and 13,050 therapy recommendations. The degree of adherence to the recommended therapies was classified into four categories. Additionally, reasons for deviations from the recommendations were categorized based on medical record reviews.
Results:
On average, 84.2% of recommendations were implemented: 68.1% were fully and 16.1% partially implemented. Deviations occurred in 8.6% of cases. The most common reasons for partial implementation were therapy changes based on new clinical findings or physician decisions (16.7%) and patient preferences (10.4%). The leading reason for complete deviation from the recommendation was lack of documentation (51.3%).
Conclusion:
Most TUB recommendations across ten medical disciplines were fully or partially implemented. However, there remains potential for improvement, particularly in ensuring consistent documentation and integrating patient preferences into clinical decision-making.
